Journal of Medicinal Chemistry · 2018 · 54 citations · 40 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyChemotherapyDrug DiscoveryCytotoxic ChemotherapyOncology PharmacologyAmino Acid Side Chain ChemistryAnticancer ActivityAnticancer ChemotherapyAnticancer Natural ProductsChemical SubstituentsDrug Candidate OptimizationLead Compound OptimizationNitrogen Mustards
to efficiently cross-link DNA. In vitro studies demonstrated the anticancer potential of these compounds at lower concentrations than those of other clinically used chemotherapeutics, such as melphalan and chlorambucil. In particular, compound 10, bearing an amino acid ester chain, is selectively cytotoxic toward breast cancer and leukemia cells that have inherently high levels of reactive oxygen species. Importantly, 10 was 10-14-fold more efficacious than melphalan and chlorambucil for triple-negative breast-cancer (TNBC) cells. Similarly, 10 is more toxic toward primary chronic-lymphocytic-leukemia cells than either chlorambucil or the lead compound, 9. The introduction of an amino acid side chain improved the solubility and permeability of 10. Furthermore, 10 inhibited the growth of TNBC tumors in xenografted mice without obvious signs of general toxicity, making this compound an ideal drug candidate for clinical development.
40
Production of large amounts of hydrogen peroxide by human tumor cells.
Ted P. Szatrowski, Carl Nathan · PubMed · 1991 · 2.5K citations
Increased Nox1 and hydrogen peroxide in prostate cancer
So Dug Lim, Carrie Sun, J. David Lambeth et al. · The Prostate · 2004 · 323 citations
Medicine, Cancer Biology, Oncology +17